NCT02598752|Completed
Loading search results
Sponsor study identifier
observational
11
1 country
1
Study Start
November 2015
Actual (reported)Primary Completion
April 10, 2020
Actual (reported)Study Completion
April 10, 2020
Actual (reported)The purpose of this study is to see if exercise fitness testing is feasible and safe in persons over 21 years of age who have been diagnosed with a hematological malignancy and are scheduled to undergo a hematopoietic stem cell transplant (HCT). Assessments in this study will look at the capacity of the body before transplantation to see if these measures can help predict how patients do after transplant.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 10, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2015
Actual (reported)November 4, 2015
Actual (reported)November 6, 2015
Actual (reported)April 10, 2020
Actual (reported)April 10, 2020
Actual (reported)VO2peak
is a measure determined by the CPET
1 year
This observational study will evaluate the feasibility and safety of functional performance testing in patients undergoing HCT. In addition to standard of care procedures, participants will undergo a CPET with a rest and stress echo, pulmonary function, and patient reported outcome questionnaires within 30 days of HCT.
Potentially eligible will be identified through and recruited from the Adult Bone Marrow Transplantation clinics at MSK.
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Jessica Scott, PhD
Memorial Sloan Kettering Cancer Center
11 participants (actual enrollment reported by the registry).
First Submitted
November 4, 2015
First Posted
November 6, 2015
Study Start
November 2015
Actual (reported)Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 10, 2020
Actual (reported)Study Completion
April 10, 2020
Actual (reported)Last Updated
April 16, 2020
Record last verified: 2020-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: